Treatment Updates: EGFR-Mutant Lung Cancer | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum

preview_player
Показать описание
Pasi A. Jänne, MD, PhD, director of the Chen-Huang Center for EGFR-Mutant Lung Cancers at Dana-Farber Cancer Institute, discusses treatment updates at the 2024 Living with EGFR-Mutant Lung Cancer Patient Forum hosted by the Chen-Huang Center.

  1. Dana-Farber Cancer Institute
  2. Dana-Farber Cancer Institute
  3. DFCI
  4. Dana-Farber
  5. cancer
  6. lung cancer
Рекомендации по теме
Treatment Updates: EGFR-Mutant 0:14:23

Treatment Updates: EGFR-Mutant Lung Cancer | 2024 Living with EGFR-Mutant Lung Cancer Patient Forum

Treating Patients With 0:00:50

Treating Patients With EGFR-Mutant Lung Cancer With Targeted Therapies

EGFR-Mutant Lung Cancer 0:14:24

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient F...

2023 Best of 0:30:32

2023 Best of Lung: Targeted Therapies in Lung Cancer

Current treatment recommendations 0:01:25

Current treatment recommendations and future directions for EGFR-mutant NSCLC

Treating Beyond Progression 0:03:28

Treating Beyond Progression in EGFR-Mutant Lung Cancer

EGFR Mutations in 0:04:10

EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023

Amivantamab and lazertinib 0:02:03

Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC

Dr. Yu on 0:01:37

Dr. Yu on Treatments for EGFR-Mutant Lung Cancer

EGFR Mutant Lung 0:45:43

EGFR Mutant Lung Cancer: 2013 Update

Treatment of EGFR 0:04:02

Treatment of EGFR Mutated NSCLC - 2022 Program: Targeted Therapies Forum - English

Q & A 0:06:02

Q & A with EGFR-Mutant Lung Cancer Experts | 2024 Living with EGFR-Mutant Lung Cancer Patient Fo...

EGFR TKIs Excite 0:01:24

EGFR TKIs Excite Treatment Landscape of EGFR-Mutant Lung Cancers

EGFR mutation positive 0:23:10

EGFR mutation positive tumors: Treatment strategies in front line and at relapse

Treating EGFR-Mutated NSCLC 0:56:52

Treating EGFR-Mutated NSCLC - 10/15/24 - Lung Cancer Living Room™

Targeted treatment with 0:20:24

Targeted treatment with EGFR TKIs: Front line options

Treatment Options: Newly 0:03:22

Treatment Options: Newly Diagnosed EGFR+ NSCLC

Emerging Data in 0:07:08

Emerging Data in EGFR-Mutant Lung Cancer

Atezolizumab with erlotinib 0:02:36

Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC

15 Years of 0:58:47

15 Years of Advances in EGFR Mutant Lung Cancer

New Treatment Option 0:01:57

New Treatment Option for EGFR Mutated Lung Cancer

EGFR Mutated NSCLC 0:03:20

EGFR Mutated NSCLC Disease Progression on Osimertinib - 2022 Program: Targeted Therapies Forum

2021 West Oncology 0:20:34

2021 West Oncology | Lung Cancer | EGFR Mutation Therapy Resistance and ADCs and TROP2

Do immune checkpoint 0:04:25

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?